Close

IsoRay (ISR) Announces Presentation of Positive Cesium-131 Brachytherapy Data at SNO Conference

June 21, 2016 6:32 AM EDT Send to a Friend
IsoRay Inc. (NYSE: ISR) announced David G. Brachman, MD, FACRO, Director of Radiation Oncology, Barrow Neurological Institute, and Clinical Professor ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login